...
首页> 外文期刊>Clinical cardiology. >Prognostic value of elevated cardiac troponin I in patients with intracerebral hemorrhage
【24h】

Prognostic value of elevated cardiac troponin I in patients with intracerebral hemorrhage

机译:脑出血患者升高心肌肌钙蛋白I的预后价值

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Although cardiac troponin has been well established as diagnostic and prognostic makers for acute coronary heart disease, the prognostic value of elevated cardiac troponin in patients with intracerebral hemorrhage (ICH) was inconsistent and not systematically evaluated. Hypothesis We proposed the hypothesis that the practical utility of cardiac troponin levels for prediction of mortality and poor outcome in ICH patients. Methods A total of 1004 patients with ICH were retrospectively reviewed and qualified for further analysis from June 2012 to December 2015. The patients were divided into different groups based on measurements of cardiac troponin I (cTnI) at the time of admission and the following day. Multivariate Cox proportional hazards analysis were performed to determine the independent prognostic value of the cTnI for patients in‐hospital mortality and poor outcomes, the receiver operator characteristic (ROC) analysis was performed to assess the predictive value of cTnI, ICH score, and combination of them. Results Serum cTnI level was an independent predictor in‐hospital mortality (positive vs negative, HR (hazard ratios) = 3.44, 95% CI (confidence interval) 1.66‐7.13, P ?.001) and poor outcomes in patients with ICH (positive vs negative, HR = 6.69, 95% CI 4.25‐10.52, P ?.001). Addition of cTnI to ICH score significantly improved the prognostic discrimination for both in‐hospital mortality and poor outcomes. Conclusion Serum cTnI levels may be valuable as predictor for in hospital mortality and poor outcomes and may be useful in the risk stratification of ICH during hospitalization.
机译:背景技术虽然心肌肌钙蛋白已被充分确定为急性冠心病的诊断和预后制造商,但脑出血(ICH)患者升高的心肌肌钙蛋白(ICH)患者的预后价值不一致,而且没有系统评价。假设我们提出了假设,即心肌肌钙蛋白水平预测死亡率和ICH患者差的结果的实用性。方法从2012年6月到2015年6月,共回顾性审查和有资格进一步分析了1004例ICH患者。根据入院时的心肌肌钙蛋白I(CTNI)的测量,患者分为不同的群体。进行多元COX比例危害分析以确定CTNI对医院内死亡率和差的结果的独立预后价值,进行接收器运营商特征(ROC)分析,以评估CTNI,ICH评分和组合的预测值他们。结果血清CTNI水平是医院内部死亡率的独立预测因素(阳性VS阴性,HR(危险比)= 3.44,95%CI(置信区间)1.66-7.13,P <β.001)和ICH患者的差的结果(阳性Vs阴性,HR = 6.69,95%CI 4.25-10.52,P <α.001)。加入CTNI至ICH评分显着改善了院内死亡率和差的成果的预后鉴别。结论血清CTNI水平可能是有价值的,作为医院死亡率和差的成果的预测因子,可用于住院期间ICH的风险分层。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号